Application of Recombinant VII Activated Coagulation Factor for Children with Resistant Coagulopathy Caused Sepsis
Purpose: To investigate the effectiveness of recombinant VII activated coagulation factor in complex therapy of children with resistant coagulopathy caused by sepsis. Materials and Methods: 38 children from 2 months to 17 years old were investigated with resistant coagulopathy caused by sepsis and u...
Saved in:
Main Authors: | N. Bgane, A. Trembach |
---|---|
Format: | Article |
Language: | English |
Published: |
State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
2010-06-01
|
Series: | Медицинский вестник Юга России |
Subjects: | |
Online Access: | https://www.medicalherald.ru/jour/article/view/1257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The comparing of acute effects of two training models aerobic and resistance on the clotting times in young women students
by: M. Rahmani Ghobadi, et al.
Published: (2018-12-01) -
The consistent use of recombinant and plasma coagulation factors in the intensive care of massive obstetric hemorrhage
by: A. V. Kuligin, et al.
Published: (2020-06-01) -
THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
by: N. A. TREKOVA, et al.
Published: (2019-07-01) -
Effect of Hemodilution <i>in vitro</i> and <i>in vivo</i> on the Hemostatic System
by: A. A. Kinzersky, et al.
Published: (2021-08-01) -
The features of the mode of delivery in patients with congenital deficiency of coagulation factor VII: case reports
by: A. Yu. Bulanov, et al.
Published: (2020-12-01)